Trials / Active Not Recruiting
Active Not RecruitingNCT05237908
Clinical Outcome and Fusion Rate of 3D Printed Interbody Fusion Cages and Titanium Coated PEEK Cages
Prospective, Randomized, Single-Blind Study for the Evaluation of the Clinical Outcome and the Fusion Rate of 3D Printed Interbody Fusion Cages and Titanium Coated PEEK Cages in Transforaminal Lumbar Interbody Fusion
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 78 (estimated)
- Sponsor
- Aesculap AG · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, Randomized, Single-Blind Study for the Evaluation of the Clinical Outcome and the Fusion Rate of 3D Printed Interbody Fusion Cages and Titanium Coated PEEK Cages in Transforaminal Lumbar Interbody Fusion
Detailed description
This clinical study is a regulatory Post Market Clinical Follow-Up (PMCF) measure and is aiming to collect clinical data on the performance and safety of the TSPACE® 3D implants. It is designed as a prospective, randomized, single-blind, non-interventional study in order to gain clinical data within the routine clinical application of the investigational device. The study shall answer the question if there are detectable differences between the established titanium coated Polyether Ether Ketone (PEEK) cages of the manufacturer and the new 3D printed cages. Differences shall be observed in terms of clinical outcome, quality of life, patient satisfaction, radiological outcome and occurrence of Adverse Events / Serious Adverse Events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transforaminal Lumbar Interbody Fusion | Interbody Fusion means the operative immobilization or ankylosis of two or more vertebrae by fusion of the vertebral bodies with a short bone graft or often with diskectomy or laminectomy. (From Blauvelt and Nelson, A Manual of Orthopaedic Terminology, 5th ed, p236; Dorland, 28th ed |
Timeline
- Start date
- 2022-02-18
- Primary completion
- 2023-05-22
- Completion
- 2028-08-01
- First posted
- 2022-02-14
- Last updated
- 2025-06-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05237908. Inclusion in this directory is not an endorsement.